A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer. Journal of women's health (2002) Tabatabai, L. S., Bloom, J., Stewart, S., Sellmeyer, D. E. 2018

Abstract

Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer.MATERIALS AND METHODS: Premenopausal women (n=206) age =55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests.RESULTS: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008±0.003g/cm2 exercise vs. -0.014±0.003g/cm2 control, p=0.24). However, among the women who did not lose lean mass during the study (n=100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001±0.005g/cm2 treatment group vs. -0.014±0.005g/cm2 control group, p=0.03). Bone turnover markers decreased significantly in both groups with no differences between groups.CONCLUSIONS: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.

View details for PubMedID 30312118